[1]
|
Bwj M, Roberts CT, Thangaratinam S, et al. Pre-eclampsia[J]. Lancet, 2016, 387:999-1011. doi: 10.1016/S0140-6736(15)00070-7 |
[2]
|
Paauw ND, Luijken K, Franx A, et al. Long-term renal and cardiovascular risk after preeclampsia: Towards screening and prevention[J]. Clin Sci(Lond), 2016, 130:239-246. doi: 10.1042/CS20150567 |
[3]
|
Possomato-Vieira JS, Khalil RA. Mechanisms of Endothelial Dysfunction in Hypertensive Pregnancy and Preeclampsia[J]. Adv pharmacol, 2016, 77:361-431. doi: 10.1016/bs.apha.2016.04.008 |
[4]
|
Nourollahpour SM, Behboodi MZ, Adam I, et al. Human infectious diseases and risk of preeclampsia: an updated review of the literature[J]. Infection, 2017, 45:589-600. doi: 10.1007/s15010-017-1031-2 |
[5]
|
姚敏, 李艳梅.根除幽门螺杆菌四联疗法对胃肠道微生态的影响[J].协和医学杂志, 2019, 10(3):268-271. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=xhyx201903015 |
[6]
|
Zamani M, Ebrahimtabar F, Zamani V, et al. Systematic review with meta-analysis: the worldwide prevalence of Helicobacter pylori infection[J]. Aliment Pharmacol Ther, 2018, 47:868-876. doi: 10.1111/apt.14561 |
[7]
|
Nejati S, Karkhah A, Darvish H, et al. Influence of Helicobacter pylori virulence factors CagA and VacA on pathogen-esis of gastrointestinal disorders[J]. Microb Pathog, 2018, 117:43-48. doi: 10.1016/j.micpath.2018.02.016 |
[8]
|
Cardaropoli S, Rolfo A, Piazzese A, et al. Helicobacter pylori's virulence and infection persistence define pre-eclampsia complicated by fetal growth retardation[J]. World J Gastroenterol, 2011, 17:5156-5165. doi: 10.3748/wjg.v17.i47.5156 |
[9]
|
Zhan YL, Si MY, Li MS, et al. The risk of Helicobacter pylori infection for adverse pregnancy outcomes: A systematic review and meta analysis[J]. Helicobacter, 2019, 24:e12562. doi: 10.1111/hel.12562 |
[10]
|
Ponzetto A, Cardaropoli S, Piccoli E, et al. Pre-eclampsia is associated with Helicobacter pylori seropositivity in Italy[J]. J Hypertens, 2006, 24:2445-2449. doi: 10.1097/HJH.0b013e3280109e8c |
[11]
|
Ahmed MA, Hassan NG, Omer ME, et al. Helicobacter pylori and Chlamydia trachomatis in Sudanese women with preeclampsia[J]. J Mater Fetal Neonatal Med, 2020, 33:2023-2026. doi: 10.1080/14767058.2018.1536738 |
[12]
|
Simone ND, Tersigni C, Cardaropoli S, et al. Helicobacter pylori infection contributes to placental impairment in preeclampsia: basic and clinical evidences[J]. Helicobacter, 2017, 22:e12347. doi: 10.1111/hel.12347 |
[13]
|
den Hollander WJ, Schalekamp-Timmermans S, Holster IL, et al. Helicobacter pylori colonization and pregnancies complicated by preeclampsia, spontaneous prematurity, and small for gestational age birth[J]. Helicobacter, 2016, 22:e12364. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=10.1111/hel.12364 |
[14]
|
Elkhouly NI, Elkelani OA, Elhalaby AF, et al. Relation between Helicobacter pylori infection and severe pre-eclampsia complicated by intrauterine growth restriction in a rural area in Egyp[J]. J Obstet Gynaecol, 2016, 36:1046-1049. doi: 10.1080/01443615.2016.1196169 |
[15]
|
Mosbah A, Nabiel Y. Helicobacter pylori, Chlamydiae pneumoniae and trachomatis as probable etiological agents of preeclampsia[J]. J Mater Fetal Neonatal Med, 2016, 29:1607-1612. doi: 10.3109/14767058.2015.1056146 |
[16]
|
Kuo FC, Wu CY, Kuo CH, et al. The Utilization of a New Immunochromatographic Test in Detection of Helicobacter pylori Antibody from Maternal and Umbilical Cord Serum[J]. Biomed Res Int, 2014, 2014:568410. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=Doaj000003930533 |
[17]
|
Cardaropoli S, Giuffrida D, Piazzese A, et al. Helicobacter pylori seropositivity and pregnancy-related diseases: a prospective cohort study[J]. J Reprod Immunol, 2015, 109:41-47. doi: 10.1016/j.jri.2015.02.004 |
[18]
|
ÜstÜn Y, Engin-ÜstÜn Y, Özkaplan E, et al. Association of Helicobacter pylori infection with systemic inflammation in preeclampsia[J]. J Matern Fetal Med, 2010, 23:311-314. doi: 10.3109/14767050903121456 |
[19]
|
Aksoy H, Ozkan A, Aktas F, et al. Helicobacter pylori seropositivity and its relationship with serum malondialdehyde and lipid profile in preeclampsia[J]. J Clin Lab Anal, 2010, 23:219-222. |
[20]
|
Pugliese A, Beltramo T, Todros T, et al. Interleukin-18 and gestosis: correlation with Helicobacter pylori seropositivity[J]. Cell Biochemi Funct, 2008, 26:817-819. doi: 10.1002/cbf.1503 |
[21]
|
Bellos I, Daskalakis G, Pergialiotis V. Helicobacter pylori infection increases the risk of developing preeclampsia: A meta-analysis of observational studies[J]. Int J Clin Pract, 2018, 72:e13064. doi: 10.1111/ijcp.13064 |
[22]
|
Nourollahpour SM, Mohammad RS, Adam I, et al. Helicobacter pylori infection and risk of preeclampsia: a systematic review and meta-analysis[J]. J Matern Fetal Neonatal Med, 2019, 32:324-331. doi: 10.1080/14767058.2017.1378331 |
[23]
|
郭晗, 张云聪, 杨硕, 等.子痫前期发病机制的研究进展[J].临床检验杂志, 2018, 36:439-443. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=lcjyzz201806011 |
[24]
|
Franceschi F, Di Simone N, D'Ippolito S, et al. Antibodies anti-caga cross-react with trophoblast cells: a risk factor for pre-eclampsia?[J]. Helicobacter, 2012, 17:426-434. doi: 10.1111/j.1523-5378.2012.00966.x |
[25]
|
Qadri Q, Rasool R, Gulzar GM, et al. H. pyloriInfection, Inflammation and Gastric Cancer[J]. J Gastrointest Cancer, 2014, 45:126-132. doi: 10.1007/s12029-014-9583-1 |
[26]
|
Buzás GM. Metabolic consequences of Helicobacter pylori infection and eradication[J]. World J Gastroenterol, 2014, 20:5226-5234. doi: 10.3748/wjg.v20.i18.5226 |
[27]
|
Adachi K, Mishiro T, Toda T, et al. Effects of Helicobacter pylori eradication on serum lipid levels[J]. J Clin Biochem Nutr, 2018, 62:264-269. doi: 10.3164/jcbn.17-88 |
[28]
|
王广娇, 杨孜.脂代谢和脂肪酸代谢与子痫前期[J].中国实用妇科与产科杂志, 2018, 34:18-22. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=zgsyfkyckzz201809005 |
[29]
|
Adank MC, Benschop L, Peterbroers KR, et al. Is maternal lipid profile in early pregnancy associated with pregnancy complications and blood pressure in pregnancy and long-term postpartum?[J]. Am J Obstet Gynecol, 2019, 221:150.e1-150.e13. doi: 10.1016/j.ajog.2019.03.025 |
[30]
|
Riise HKR, Sulo G, Tell GS, et al. Hypertensive pregnancy disorders increase the risk of maternal cardiovascular disease after adjustment for cardiovascular risk factors[J]. Int J Cardiol, 2019, 282:81-87. doi: 10.1016/j.ijcard.2019.01.097 |
[31]
|
Veerbeek JHW, Hermes W, Breimer AY, et al. Cardiovascular disease risk factors after early-onset preeclampsia, late-onset preeclampsia, and pregnancy-induced hypertension[J]. Hypertension, 2015, 65:600-606. doi: 10.1161/HYPERTENSIONAHA.114.04850 |
[32]
|
Alsnes IV, Vatten LJ, Fraser A, et al. Hypertension in Pregnancy and Offspring Cardiovascular Risk in Young Adulthood Novelty and Significance[J]. Hypertension, 2017, 69:591-598. doi: 10.1161/HYPERTENSIONAHA.116.08414 |
[33]
|
Davi G, Neri M, Falco A, et al. Helicobacter pylori infection causes persistent platelet activation in vivo through enhanced lipid peroxidation[J]. Arteriosclerosis Thromb Vasc Biol, 2005, 25:246-251. doi: 10.1161/01.ATV.0000147128.10278.99 |
[34]
|
Franceschi F, Niccoli G, Ferrante G, et al. CagA antigen of Helicobacter pylori and coronary instability: insight from a clinico-pathological study and a meta-analysis of 4241 cases[J]. Atherosclerosis, 2009, 202:535-542. doi: 10.1016/j.atherosclerosis.2008.04.051 |